Structure of 3 2R5S 5 4 Fluorophenyl 2 S 4 fluorophenylamino4 trimethylsilyl oxyphenylmethyl 1 oxo 5 trimethylsily oxypentyl 4 phenyl 4S 2 oxazolidinone CAS 272778 12 8 - 3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl(amino)]][4-[trimethylsilyl]-oxy]phenyl]methyl]-1-oxo-5-[(trimethylsily)-oxy]pentyl]-4-phenyl-(4S)-2-oxazolidinone CAS 272778-12-8 Iden­ti­fi­ca­tion Prop­er­ties Safe­ty Data Spec­i­fi­ca­tions and Oth­er Information Links

Iden­ti­fi­ca­tion

CAS Number

272778-12-8

Name

3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl(amino)]][4-[trimethylsilyl]-oxy]phenyl]methyl]-1-oxo-5-[(trimethylsily)-oxy]pentyl]-4-phenyl-(4S)-2-oxa­zo­lidi­none

Syn­onyms

(4S)-3-{(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl)amino]{4-[(trimethylsilyl)oxy]phenyl}methyl]-5-[(trimethylsilyl)oxy]pentanoyl}-4-phenyl-1,3-oxazolidin-2-one [ACD/IUPAC Name] (4S)-3-{(2R,5S)-5-(4-Fluorophényl)-2-[(S)-[(4-fluorophényl)amino]{4-[(triméthylsilyl)oxy]phényl}méthyl]-5-[(triméthylsilyl)oxy]pentanoyl}-4-phényl-1,3-oxazolidin-2-one [French] [ACD/IUPAC Name] (4S)-3-{(2R,5S)-5-(4-Fluorphenyl)-2-[(S)-[(4-fluorphenyl)amino]{4-[(trimethylsilyl)oxy]phenyl}methyl]-5-[(trimethylsilyl)oxy]pentanoyl}-4-phenyl-1,3-oxazolidin-2-on [Ger­man] [ACD/IUPAC Name] 2-Oxa­­zo­­lidi­none, 3-[(2R,5S)-5-(4-fluorophenyl)-2-[(S)-[(4-fluorophenyl)amino][4-[(trimethylsilyl)oxy]phenyl]methyl]-1-oxo-5-[(trimethylsilyl)oxy]pentyl]-4-phenyl-, (4S)- [ACD/​Index Name] (S)-3-((2R,5S)-5-(4-Fluorophenyl)-2-((S)-((4-fluorophenyl)amino)(4-((trimethylsilyl)oxy)phenyl)methyl)-5-((trimethylsilyl)oxy)pentanoyl)-4- (S)-3-((2R,5S)-5-(4-Fluorophenyl)-2-((S)-((4-fluorophenyl)amino)(4-((trimethylsilyl)oxy)phenyl)methyl)-5-((trimethylsilyl)oxy)pentanoyl)-4-phenyloxazolidin-2-one 272778-12-8 [RN] 2-Oxa­­zo­­lidi­none, 3-[(2R,5S)-5-(4-fluorophenyl)-2-[(S)-[(4-fluorophenyl)amino][4-[(trimethyl silyl)oxy]phenyl]methyl]-1-oxo-5-[(trimethylsilyl)oxy]pentyl]-4-phenyl-, (4S)- 3-(2R,5S)-5-(4-fluorophenyl)-2-(S)-(4-fluorophenyl(amino)4-trimethylsilyl-oxyphenylmethyl-1-oxo-5-(trimethylsily)-oxypentyl-4-phenyl-(4S)-2-oxa­zo­lidi­none 3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl(amino)]][4-[trimethylsilyl]-oxy]phenyl]methyl]-1-oxo-5-[(trimethylsily)-oxy]pentyl]-4-phenyl-(4S)-2-oxa­zo­lidi­none 3-{5-(4-Fluoro-phenyl)-2-[(4-fluoro-phenylamino)-(4-trimethylsilanyloxy-phenyl)-methyl]-5-trimethylsilanyloxy-pentanoyl}-4-phenyl-oxazolidin-2-one MFCD08460200 [MDL num­ber]

Mol­e­c­u­lar Structure

Structure of 3 2R5S 5 4 Fluorophenyl 2 S 4 fluorophenylamino4 trimethylsilyl oxyphenylmethyl 1 oxo 5 trimethylsily oxypentyl 4 phenyl 4S 2 oxazolidinone CAS 272778 12 8 - 3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl(amino)]][4-[trimethylsilyl]-oxy]phenyl]methyl]-1-oxo-5-[(trimethylsily)-oxy]pentyl]-4-phenyl-(4S)-2-oxazolidinone CAS 272778-12-8

Struc­ture of 3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl(amino)]][4-[trimethylsilyl]-oxy]phenyl]methyl]-1-oxo-5-[(trimethylsily)-oxy]pentyl]-4-phenyl-(4S)-2-oxa­zo­lidi­none CAS 272778-12-8

SMILES

C[Si](C)(C)OC1=CC=C(C=C1)[C@H]([C@@H](CC[C@@H](C2=CC=C(C=C2)F)O[Si](C)(C)C)C(=O)N3[C@H](COC3=O)C4=CC=CC=C4)NC5=CC=C(C=C5)F

Std­InChI

InChI=1S/C39H46F2N2O5Si2/c1-49(2,3)47-33-22-14-29(15-23-33)37(42-32-20-18-31(41)19-21-32)34(24-25-36(48-50(4,5)6)28-12-16-30(40)17-13-28)38(44)43-35(26-46-39(43)45)27-10-8-7-9-11-27/h7-23,34-37,42H,24-26H2,1-6H3/t34-,35-,36+,37-/m1/s1

Std­InChIKey

XXMINDVVB­VJXLN-GOF­­GAP­­PUSA-N

Mol­e­c­u­lar Formula

C39H46F2N2O5Si2

Mol­e­c­u­lar Weight

716.96

Prop­er­ties

Appear­ance

White or off white pow­der

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our 3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl(amino)]][4-[trimethylsilyl]-oxy]phenyl]methyl]-1-oxo-5-[(trimethylsily)-oxy]pentyl]-4-phenyl-(4S)-2-oxa­zo­lidi­none CAS 272778-12-8

Stan­dard

Enter­prise stan­dard

Iden­ti­fi­ca­tion Methods

HNMR/HPLC

Puri­ty

98%min

Water

0.5%max

Sin­gle Impurity

1.5%max

Total Impu­ri­ties

2.0%max

Stor­age

Under the room tem­per­a­ture and away from light

Appli­ca­tion

Used as the phar­ma­ceu­ti­cal inter­me­di­ates of the Eze­tim­ibe

Links

This prod­uct is devel­oped by our RandD com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd(http://​www​.cam​ing​.com/), and here is the cor­re­spond­ing linkhttp://​www​.cam​ing​.com/​3​-​2​r​5​s​-​5​-​4​-​f​l​u​o​r​o​p​h​e​n​y​l​-​2​-​s​-​4​-​f​l​u​o​r​o​p​h​e​n​y​l​a​m​i​n​o​4​-​t​r​i​m​e​t​h​y​l​s​i​l​y​l​-​o​x​y​p​h​e​n​y​l​m​e​t​h​y​l​-​1​-​o​x​o​-​5​-​t​r​i​m​e​t​h​y​l​s​i​l​y​-​o​x​y​p​e​n​t​y​l​-​4​-​p​h​e​n​y​l​-​4​s​-​2​-​o​x​a​z​o​l​i​d​i​n​o​n​e​-​c​a​s​-​2​7​2​7​7​8​-​1​2​-8/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you short­ly (Please change screen to hor­i­zon­tal for com­plete brows­ing if you are check­ing Wat­son on your mobile phone). 

























    Please prove you are human by select­ing the house.




    andD pur­pose. It may be tox­ic or haz­ardous, and should be han­dled only by qual­i­fied indi­vid­u­als trained in lab­o­ra­to­ry pro­ce­dures. The buy­er will be respon­si­ble to warn and inform any per­son that may be in con­tact with the prod­uct of the poten­tial risks and haz­ards, as well as to ensure that pur­chase, use and dis­pos­al of the prod­uct com­ply with local laws and regulations.